Showing 1761-1770 of 1922 results for "".
- Alcon Launches Project Presbyopia to Educate Eye Care Providers and Consumers During Presbyopia Awareness Monthhttps://modernod.com/news/alcon-launches-project-presbyopia-to-educate-eye-care-providers-and-consumers-during-presbyopia-awareness-month/2476460/Alcon is launching Project Presbyopia as part of Presbyopia Awareness Month in April. Project Presbyopia is an ongoing effort to educate consumers about how to recognize signs and symptoms of vision changes, uncover more intuitive language for the condition, and drive existing and emerging presby
- Eurazeo Capital to Acquire DORC From Montaguhttps://modernod.com/news/eurazeo-capital-to-acquire-dorc-from-montagu/2476442/Eurazeo Capital will acquire ophthalmic instrument maker DORC (Dutch Ophthalmic Research Center) from Montagu Private Equity for about EUR300 million. Established in 1983 and headquartered in the Netherlands, DORC is a specialist in vitreoretinal surgery,
- The American Optometric Association Highlights the Importance of Early Intervention through Annual Eye Examshttps://modernod.com/news/the-american-optometric-association-highlights-the-importance-of-early-intervention-through-annual-eye-exams/2479593/More than 40 percent of Americans are myopic and that number is increasing at an alarming rate, especially among school-aged children. In fact, one in four parents have a child with myopia, and about three quarters of children with myopia were diagnosed between the ages of 3 and 12, according to
- Pharmaceutical Executives Field Questions at US Senate Hearing Over Drug Pricinghttps://modernod.com/news/pharmaceutical-executives-field-questions-at-us-senate-hearing-over-drug-pricing/2476258/CEOs and senior executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson appeared before the US Senate Finance Committee on Tuesday to testify about the high cost of drugs in the country. The executives, who continued to blame pharmacy
- Heidelberg OCT2 Module Successfully Installed at the International Space Stationhttps://modernod.com/news/heidelberg-oct2-module-successfully-installed-at-the-international-space-station/2476295/Heidelberg Engineering announced that its Spectralis imaging platform with the company’s next-generation OCT2 Module has been successfully installed at the International Space Station (ISS) and is now fully operational. NASA launched the Spectralis with OCT2 Module to the ISS aboard the An
- Our Artificial Cornea Breakthrough Could Lead to Self-Assembling Organshttps://modernod.com/news/our-artificial-cornea-breakthrough-could-lead-to-self-assembling-organs/2476305/For every person in the world who receives a cornea transplant, there are 69 others who still need one. That leaves about 12.5m people with limited sight because there aren’t enough eye donors. But what if we cou
- FDA Commissioner Gottlieb Announces Efforts to Improve Assessment of REMS Programshttps://modernod.com/news/fda-commissioner-gottlieb-announces-efforts-to-improve-assessment-of-rems-programs/2479604/In an FDA statement, Commissioner Scott Gottlieb, MD, announced efforts to improve the quality of the information used to assess the effectiveness of Risk Evaluation and Mitigation Strategy (REMS) programs in supporting the safe use of medications. In making decisions about whether the ben
- FDA to Boost Staff to Help Handle Anticipated Increase in Cell and Gene Therapy Filingshttps://modernod.com/news/fda-to-boost-staff-to-help-handle-anticipated-increase-in-cell-and-gene-therapy-filings/2476185/FDA Commissioner Scott Gottlieb said Tuesday that the agency’s “eventual goal” is to add about 50 additional clinical reviewers to the group that oversees the clinical investigation, development, and review of cell and gene therapy products. He also cited the more than 800 activ
- Bausch Health to Purchase Majority of Synergy Pharmaceuticals’ Assets, Including Trulancehttps://modernod.com/news/bausch-health-to-purchase-majority-of-synergy-pharmaceuticals-assets-including-trulance/2479614/Bausch Health announced a deal to purchase nearly all of the assets of bankrupt drugmaker Synergy Pharmaceuticals for about $200 million in cash, with the transaction including the constipation treatment Trulance (plecanatide), according to FirstWord. Bausch Health CEO Joseph Papa noted that the
- Alcon Introduces New Medical Affairs Website in North America, Expanding Support for Patient Care and Clinical Communityhttps://modernod.com/news/alcon-introduces-new-medical-affairs-website-in-north-america-expanding-support-for-patient-care-and-clinical-community/2476149/Alcon recently launched a new website, AlconScience.com, for US- and Canada-based eye care professionals and academic institutions. The new medical affairs website consolidates information about Alcon’s scientific, academic, and related activities into one portal. Visitors may download clinically